Addus HomeCare Corporation (NASDAQ:ADUS – Get Free Report) has been assigned an average rating of “Moderate Buy” from the ten ratings firms that are currently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, six have assigned a buy rating and one has issued a strong buy rating on the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $135.4444.
Several brokerages have recently weighed in on ADUS. Truist Financial set a $135.00 target price on shares of Addus HomeCare and gave the stock a “buy” rating in a research note on Wednesday, January 7th. BMO Capital Markets began coverage on Addus HomeCare in a research report on Thursday, November 13th. They set a “market perform” rating and a $120.00 price objective for the company. Barclays boosted their target price on Addus HomeCare from $111.00 to $117.00 and gave the company an “underweight” rating in a report on Tuesday, November 4th. TD Cowen reaffirmed a “buy” rating on shares of Addus HomeCare in a report on Wednesday, November 5th. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of Addus HomeCare in a research report on Wednesday, January 21st.
Check Out Our Latest Analysis on Addus HomeCare
Addus HomeCare Trading Down 1.2%
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last posted its quarterly earnings data on Monday, November 3rd. The company reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.53 by $0.03. The business had revenue of $362.30 million during the quarter, compared to the consensus estimate of $354.48 million. Addus HomeCare had a return on equity of 9.53% and a net margin of 6.36%.The company’s revenue was up 25.0% compared to the same quarter last year. During the same period in the prior year, the company earned $1.30 earnings per share. On average, research analysts anticipate that Addus HomeCare will post 4.59 EPS for the current year.
Insider Buying and Selling at Addus HomeCare
In other news, EVP Darby Anderson sold 20,000 shares of the business’s stock in a transaction dated Wednesday, November 19th. The shares were sold at an average price of $109.00, for a total transaction of $2,180,000.00. Following the transaction, the executive vice president directly owned 44,144 shares in the company, valued at $4,811,696. The trade was a 31.18% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders have sold a total of 20,316 shares of company stock valued at $2,215,998 over the last quarter. 4.50% of the stock is owned by insiders.
Hedge Funds Weigh In On Addus HomeCare
Several institutional investors and hedge funds have recently added to or reduced their stakes in ADUS. Larson Financial Group LLC lifted its holdings in shares of Addus HomeCare by 133.3% in the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock valued at $28,000 after buying an additional 136 shares during the period. Private Trust Co. NA raised its position in Addus HomeCare by 65.5% in the fourth quarter. Private Trust Co. NA now owns 283 shares of the company’s stock worth $30,000 after acquiring an additional 112 shares in the last quarter. AlphaQuest LLC acquired a new stake in Addus HomeCare in the third quarter valued at $37,000. Wexford Capital LP purchased a new stake in shares of Addus HomeCare during the 3rd quarter worth $41,000. Finally, State of Wyoming acquired a new position in shares of Addus HomeCare during the 2nd quarter worth $47,000. Institutional investors and hedge funds own 95.35% of the company’s stock.
About Addus HomeCare
Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.
The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.
Read More
- Five stocks we like better than Addus HomeCare
- The day the gold market broke
- Buy this Gold Stock Before May 2026
- Forget AI, This Will Be the Next Big Tech Breakthrough
- Trump Planning to Use Public Law 63-43: Prepare Now
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
